Comparison of the efficacy and safety of esmolol, a short-acting beta blocker, with placebo in the treatment of supraventricular tachyarrhythmias. The Esmolol vs Placebo Multicenter Study Group.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples